341 related articles for article (PubMed ID: 8775468)
1. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors.
Castellano L; De Sio I; Silvestrino F; Marmo R; Del Vecchio Blanco C
Ital J Gastroenterol; 1995; 27(8):425-9. PubMed ID: 8775468
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol.
Buchner AM; Sonnenberg A
Am J Gastroenterol; 2002 Apr; 97(4):905-9. PubMed ID: 12003426
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
Acalovschi M; Blendea D; Feier C; Letia AI; Ratiu N; Dumitrascu DL; Veres A
Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of gallstones in liver cirrhosis: a sonographic survey.
Acalovschi M; Badea R; Dumitraşcu D; Varga C
Am J Gastroenterol; 1988 Sep; 83(9):954-6. PubMed ID: 3046336
[TBL] [Abstract][Full Text] [Related]
5. A necroptic study of the prevalence of cholelithiasis in liver cirrhosis.
Acalovschi M; Dumitraşcu D; Ban A; Petrescu A
Med Interne; 1986; 24(1):23-7. PubMed ID: 3704500
[TBL] [Abstract][Full Text] [Related]
6. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren's contracture, alcohol consumption, and chronic liver disease.
Attali P; Ink O; Pelletier G; Vernier C; Jean F; Moulton L; Etienne JP
Arch Intern Med; 1987 Jun; 147(6):1065-7. PubMed ID: 3592873
[TBL] [Abstract][Full Text] [Related]
8. Cholelithiasis in cirrhosis: analysis of 500 cases.
Conte D; Barisani D; Mandelli C; Bodini P; Borzio M; Pistoso S; Segala M; Aimo GP; Fraquelli M; Bianchi PA
Am J Gastroenterol; 1991 Nov; 86(11):1629-32. PubMed ID: 1951241
[TBL] [Abstract][Full Text] [Related]
9. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones.
Diehl AK; Schwesinger WH; Holleman DR; Chapman JB; Kurtin WE
Am J Gastroenterol; 1995 Jun; 90(6):967-72. PubMed ID: 7771432
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of gallstones in patients suffering from liver cirrhosis: a clinico-statistical study of 350 patients.
Grassi M; Allevato C; Mammucari S; Lazzari S; Nocchi S
Ital J Gastroenterol; 1992; 24(6):342-6. PubMed ID: 1515661
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
Hepatology; 1988; 8(4):907-13. PubMed ID: 3391520
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of gallstones in chronic liver disease is related to degree of liver dysfunction.
Elzouki AN; Nilsson S; Nilsson P; Verbaan H; Simanaitis M; Lindgren S
Hepatogastroenterology; 1999; 46(29):2946-50. PubMed ID: 10576378
[TBL] [Abstract][Full Text] [Related]
14. Gallstone prevalence in Christchurch: risk factors and clinical significance.
Chapman BA; Frampton CM; Wilson IR; Chisholm RJ; Allan RB; Burt MJ
N Z Med J; 2000 Feb; 113(1104):46-8. PubMed ID: 10777222
[TBL] [Abstract][Full Text] [Related]
15. Cholelithiasis in cirrhotic patients. (Analysis of cholelithiasis among patients with liver cirrhosis in São Paulo, Brazil).
Genzini T; de Miranda MP; de Oliveira e Silva A; de Souza CP; Silva FA; de Melo CR; dos Santos TE; Cardoso ES; Santo GC; Lee MP; D'Albuquerque LA
Arq Gastroenterol; 1996; 33(2):52-9. PubMed ID: 9109969
[TBL] [Abstract][Full Text] [Related]
16. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
17. Gallstone disease and related risk factors in a large cohort of diabetic patients.
Pagliarulo M; Fornari F; Fraquelli M; Zoli M; Giangregorio F; Grigolon A; Peracchi M; Conte D
Dig Liver Dis; 2004 Feb; 36(2):130-4. PubMed ID: 15002821
[TBL] [Abstract][Full Text] [Related]
18. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies.
Torgerson JS; Lindroos AK; Näslund I; Peltonen M
Am J Gastroenterol; 2003 May; 98(5):1032-41. PubMed ID: 12809825
[TBL] [Abstract][Full Text] [Related]
19. Chronic liver disease in diabetes mellitus.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
[TBL] [Abstract][Full Text] [Related]
20. Contribution of obesity to hepatitis C-related fibrosis progression.
Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
